172 related articles for article (PubMed ID: 2357784)
21. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
22. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
Heiner JS; Greendale GA; Kawakami AK; Lapolt PS; Fisher M; Young D; Judd HL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
[TBL] [Abstract][Full Text] [Related]
23. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
[TBL] [Abstract][Full Text] [Related]
24. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
25. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
Ruutiainen K
Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
[TBL] [Abstract][Full Text] [Related]
26. Treatment of hirsutism with spironolactone.
Tremblay RR
Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
[TBL] [Abstract][Full Text] [Related]
27. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Zemtsov A; Wilson L
Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
[No Abstract] [Full Text] [Related]
29. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
30. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Guzelmeric K; Seker N; Unal O; Turan C
Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
[TBL] [Abstract][Full Text] [Related]
31. Cyproterone acetate and the treatment of hirsutism.
Fraser IS; Shearman RP; Allen JK; McCarron G
Aust N Z J Obstet Gynaecol; 1983 May; 23(2):93-8. PubMed ID: 6226279
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hirsutism with spironolactone.
Cumming DC; Yang JC; Rebar RW; Yen SS
JAMA; 1982 Mar; 247(9):1295-8. PubMed ID: 7199587
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.
Castelo-Branco C; Martínez de Osaba MJ; Pons F; Fortuny A
Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850
[TBL] [Abstract][Full Text] [Related]
34. [Hirsutism].
van Zuuren EJ; Pijl H
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
37. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
38. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
39. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
40. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
